Volume 18, Issue 4 pp. 192-196

A study of adaptive responses in cell signaling in migraine and cluster headache: correlations between headache type and changes in gene expression

IM Gardiner

IM Gardiner

Division of Neurosciences, Imperial College School of Medicine at Charing Cross Hospital London, UK

Search for more papers by this author
F Ahmed

F Ahmed

Division of Neurosciences, Imperial College School of Medicine at Charing Cross Hospital London, UK

Search for more papers by this author
TJ Steiner

TJ Steiner

Division of Neurosciences, Imperial College School of Medicine at Charing Cross Hospital London, UK

Search for more papers by this author
A McBain

A McBain

Division of Neurosciences, Imperial College School of Medicine at Charing Cross Hospital London, UK

Search for more papers by this author
C Kennard

C Kennard

Division of Neurosciences, Imperial College School of Medicine at Charing Cross Hospital London, UK

Search for more papers by this author
J de Belleroche

Corresponding Author

J de Belleroche

Division of Neurosciences, Imperial College School of Medicine at Charing Cross Hospital London, UK

J de Belleroche, Division of Neurosciences, Imperial College School of Medicine at Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK. Tel. +44 181 846 7052, fax. +44 181 846 7099, e-mail. [email protected].Search for more papers by this author
First published: 04 January 2002
Citations: 4

Abstract

The project was an investigation into whether changes in the expression of G-proteins underlie altered cell signaling in migraine and cluster headache. The basis for this assumption is that altered physiological responses are seen in migraineurs and that differences in cell signaling are detected biochemically in various cell types isolated from peripheral blood. Levels of three G-protein mRNAs—Gsα, Giα, and Gqα were quantified in lymphocytes from clinically well-defined migraine and cluster headache patients and correlated with headache type and influence of drug treatment. Giα mRNA was reduced by 50% in all migraine patients compared with control subjects; similarly in patients with or without aura, in patients with a migraine headache at the time of sampling, and patients in a quiescent state. No reduction in the levels of Gsα or Gqα mRNA were seen in migraine patients. A smaller reduction was seen in cluster headache patients, most marked in those without medication. Levels of Gsα. mRNA were significantly reduced in cluster headache patients compared with migraine patients. The marked down-regulation of Giα mRNA in migraine, whether quiescent or acute, indicates either an adaptive response to headache in this group of patients or that low levels of Giα mRNA make individuals more susceptible to migraine.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.